Our results showed that angiogenesis may play a role in NP development; both Ang-1 and VEGF-A expression are elevated in NP tissues in comparison to normal nasal mucosa tissues and both bevacizumab and propranolol have showed antiangiogenic effects on nasal polyposis tissues. The gene discussed is ANGPT1; the disease is Nasal polyposis.